Top Markets
Coin of the day
Immunovia AB Immunovia AB

Immunovia AB

IMMNOV
Rank in Stocks #34134
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Share Price
$0.018005
Last synced: 2026-08-14
Market Cap
$6.17M
Change (1 day)
-1.71%
Change (1 year)
-60.12%
Country
SE
Trade Immunovia AB (IMMNOV)

Category

Earnings for Immunovia AB (IMMNOV)
Earnings in 2026 TTM: 0
According to Immunovia AB latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Immunovia AB from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US